An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report.
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show.
Young Black and Hispanic cancer patients face poorer survival odds than their white counterparts, even from some cancers that are highly curable, a new study finds.
Some types of cancer may alter the appearance and function of the heart, according to new research that analyzed people's hearts before cancer treatment.
